Andrew Yun, MD
Orthopaedic Surgery · Beverly Hills, CANPI 1083674410
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $328,772 of the $361,562 with a category attached, or 90.9%. Smith+Nephew accounts for 90.9% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $98,839, 4.9 times the $20,294 reported in 2019. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 153 payments — averaging $2363.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$329K
- Stryker$13K
- UOC USA Inc$10K
- Avanos Medical$9K
- Zimmer Biomet$169
- Vertex$166
- plus $132 from 3 others
What the payments were for
- Royalty or licence$328,77291%
- Consulting fees$10,1753%
- Speaking & faculty fees$8,7002%
- Travel & lodging$5,6272%
- Food & beverage$8,2882%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 35 | $328,772 |
| Stryker | 101 | $12,876 |
| UOC USA Inc | 5 | $10,332 |
| Avanos Medical | 6 | $9,115 |
| Zimmer Biomet | 2 | $169 |
| Vertex | 1 | $166 |
| Innovation Technologies Inc | 1 | $59 |
| Boston Scientific | 1 | $43 |
| Encore Medical, LP | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$482,522
- CONFORMITY$10,175
- MAKO$9,688
- ON-Q$8,700
- JII Unicondylar Knee System$8,387
- ON-Q* PUMP AND ACCESSORIES$327
- PROFYLE$173
- JOURNAVX$166
- Persona$141
- HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET$138
- EXETER$137
- INSIGNIA$131
How this compares
$361,562 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 153 | $1,018 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Beverly Hills
- Brad PenenbergBeverly Hills$4M
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.